 "Glenmark Pharma surges on strong June quarter results")
Glenmark Pharmaceuticals has surged 6% to Rs 630 in otherwise weak market on NSE after reporting a strong 44% year-on-year (yoy) jump in consolidated profit at Rs 185 crore on back of strong revenue growth for the quarter ended June 2014. The company had profit of Rs 129 crore in year ago quarter.
For the first quarter ended June 30, 2014, Glenmark’s consolidated revenue was at Rs 1,487 crore as against Rs 1,238 crore in the corresponding quarter recording a growth of 20%. EBITDA or operating profit margins improved 300 basis points to 23% from 20%.
"We have delivered strong results backed by good performances by our India, Rest of the World, Europe and LATAM (Latin America) businesses. While we outperformed in the Indian Pharmaceutical market with a growth of over 20%," company's Chairman and MD Glenn Saldanha said.
The stock opened at Rs 610 and touched a high of Rs 633 on NSE. A combined 1.33 million shares changed hands on the counter so far NSE and BSE.
For the first quarter ended June 30, 2014, Glenmark’s consolidated revenue was at Rs 1,487 crore as against Rs 1,238 crore in the corresponding quarter recording a growth of 20%. EBITDA or operating profit margins improved 300 basis points to 23% from 20%.
"We have delivered strong results backed by good performances by our India, Rest of the World, Europe and LATAM (Latin America) businesses. While we outperformed in the Indian Pharmaceutical market with a growth of over 20%," company's Chairman and MD Glenn Saldanha said.
The stock opened at Rs 610 and touched a high of Rs 633 on NSE. A combined 1.33 million shares changed hands on the counter so far NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%